萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Mehdi S Mirsaeidi, MD, MPH

Pulmonologist, Critical Care Medicine Physician

4.9 /5 227 ratings

Additional languages:: Persian

Request appointment online

Research at a glance

Top areas of exploration

Mycobacterium tuberculosis , 21 publications
Antitubercular Agents , 20 publications
COVID-19 , 18 publications
Tuberculosis, Pulmonary , 15 publications

Research activity

241 publications

9,596 citations

Why is this important?

Active clinical trials

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis

Investigator: Mehdi S Mirsaeidi
Status: Accepting Candidates
Ages: 18 Years - 75 Years
Sexes: All

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home 鈥� a multi-center randomized controlled trial

Investigator: Mehdi S Mirsaeidi
Status: Accepting Candidates
Ages: 30 Years - NA Years
Sexes: All

A Study of the Efficacy and Safety of Treatment With MNKD-101 When Added to GBT in Participants with Pulmonary Nontuberculous Mycobacterial Infection

Investigator: Mehdi S Mirsaeidi
Status: Accepting Candidates
Ages: 18 Years - 85 Years
Sexes: All

My publications

241 publications

2025

Interstitial Lung Disease is a major contributor to mortality in patients with Connective Tissue Diseases

CHEST Pulmonary

2024

Acute cardiovascular effects of electronic cigarettes: a systematic review and meta-analysis.

European heart journal open

鈥�

2024

Associations of Social Determinants and Community Resilience with Lung Cancer Incidence and Mortality in the United States

American Journal of Respiratory and Critical Care Medicine

2024

Editorial: A year in review: discussions in pulmonary medicine.

Frontiers in medicine

鈥�

2024

Genome sequencing of Pseudomonas aeruginosa phages; 萝莉社_RH7 and 萝莉社_RH9

Microbiology Resource Announcements

鈥�